Search Results 121-130 of 16259 for monoclonal antibody
Monoclonal antibodies can block cancer growth in different ways. ... Prior anti-cancer monoclonal antibody < 28 days prior to registration or who ...
The purpose of this study is to assess the effects of DCSZ11, an anti-CD93 monoclonal antibody, as a monotherapy in patients with advanced or metastatic solid ...
... monoclonal antibody. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...
A blood test might show nontypical antibodies that interrupt the receptor sites where nerves signal your muscles to move. ... Monoclonal antibody. Rituximab ( ...
Monoclonal antibodies such as trastuzumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.
The medication, given as a single-dose injection prior to or during RSV season, is a monoclonal antibody. It is intended for babies born during or entering ...
Monoclonal antibodies, such ... Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin.
Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Prior anti-cancer monoclonal antibody (mAb) =< 4 weeks prior to registration ...
Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2. This may restrain new blood vessel formation therefore ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.